Should palonosetron be a preferred 5-HT3 receptor antagonist for chemotherapy-induced nausea and vomiting? An updated systematic review and meta-analysis
2018 ◽
Vol 26
(8)
◽
pp. 2519-2549
◽
2018 ◽
Vol 7
(2)
◽
pp. 221-233
◽
2019 ◽
Vol 24
(12)
◽
pp. 1593-1600
◽
Keyword(s):